diclofenac has been researched along with EBV Infections in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Natesan Pushparaj, P | 1 |
| Damiati, LA | 1 |
| Denetiu, I | 1 |
| Bakhashab, S | 1 |
| Asif, M | 1 |
| Hussain, A | 1 |
| Ahmed, S | 1 |
| Hamdard, MH | 1 |
| Rasool, M | 1 |
1 other study available for diclofenac and EBV Infections
| Article | Year |
|---|---|
Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods.
Topics: A549 Cells; Biological Products; COVID-19 Drug Treatment; Cytokines; Diclofenac; Epstein-Barr Virus | 2022 |